 |
 |

Investigation of Mechanisms in Toxic Epidermal Necrolysis Induced by Carbamazepine
Peter S. Friedmann, MD;
Ian Strickland;
Munir Pirmohamed, PhD;
B. Kevin Park, PhD
Arch Dermatol. 1994;130(5):598-604.
Abstract
 |  |
Background Erythema multiforme and toxic epidermal necrolysis can occur as serious and even life-threatening adverse drug reactions. The underlying mechanisms are unknown, but evidence suggests that affected individuals may have impaired capacity to detoxify reactive intermediate drug metabolites. Such intermediates may be directly toxic or may react with host tissues to form antigens, evoking an immune response. We describe our investigation of a patient with carbamazepine-induced erythema multiforme and toxic epidermal necrolysis. The inflammatory infiltrate was examined immunocytochemically in lesional skin specimens from the patient, in the patient's patch test response to carbamazepine, and in lesional skin specimens from five other patients with drug-induced erythema multiforme. The patient's lymphocytes were examined both for susceptibility to cytotoxic damage by liver microsome—induced carbamazepine metabolites and for proliferative responses to native carbamazepine, which might indicate cell-mediated immune sensitization.
Observations Lesions of toxic epidermal necrolysis were more florid, but findings were essentially similar in all the skin samples examined. In the dermis there were CD14+ macrophages, CD1a+ Langerhans cells, and CD3+, CD45RO+ T cells. The CD4-CD8 T-cell ratio was 2:1, and 10% of the T cells were CD25+, suggesting activation by recent encounter with antigen. The epidermis contained CD14+ macrophages and T cells, but the CD8+ cells out-numbered the CD4+ cells. Up to 25% of the T cells were CD25+. Lymphocyte proliferation was not induced by native carbamazepine, but the patient's lymphocytes were significantly more susceptible to cytotoxic killing by liver microsome—induced carbamazepine intermediates.
Conclusions The inflammatory reaction in skin affected by erythema multiforme and toxic epidermal necrolysis was rich in CD8+ T cells, suggesting an immune cytotoxic reaction. The patient appeared to have a reduced capacity to detoxify reactive intermediates. This, together with the lack of lymphocyte response to native drug but a positive patch test response, suggests that the immune response may be directed at drug-modified epidermal cells.
(Arch Dermatol. 1994;130:598-604)
Author Affiliations
From the Departments of Dermatology (Dr Friedmann and Mr Strickland) and Pharmacology and Therapeutics (Drs Pirmohamed and Park), Liverpool (England) University.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Management of toxic epidermal necrolysis and related syndromes
Mukasa and Craven
Postgrad. Med. J. 2008;84:60-65.
ABSTRACT
| FULL TEXT
Phenytoin and carbamazepine cross reactivity: report of a case and review of literature
Misra et al.
Postgrad. Med. J. 2003;79:703-704.
ABSTRACT
| FULL TEXT
Hypersensitivity Reactions to Carbamazepine: Characterization of the Specificity, Phenotype, and Cytokine Profile of Drug-Specific T Cell Clones
Naisbitt et al.
Mol. Pharmacol. 2003;63:732-741.
ABSTRACT
| FULL TEXT
Cutaneous Drug Reactions
Svensson et al.
Pharmacol. Rev. 2001;53:357-379.
ABSTRACT
| FULL TEXT
TNF{{alpha}} promoter region gene polymorphisms in carbamazepine-hypersensitive patients
Pirmohamed et al.
Neurology 2001;56:890-896.
ABSTRACT
| FULL TEXT
Classification, Clinical Manifestations, and Immunopathological Mechanisms of the Epithelial Variant of Paraneoplastic Autoimmune Multiorgan Syndrome: A Reappraisal of Paraneoplastic Pemphigus
Nguyen et al.
Arch Dermatol 2001;137:193-206.
ABSTRACT
| FULL TEXT
Fortnightly review: Adverse drug reactions
Pirmohamed et al.
BMJ 1998;316:1295-1298.
FULL TEXT
Role of Delayed Cellular Hypersensitivity and Adhesion Molecules in Amoxicillin-Induced Morbilliform Rashes
Barbaud et al.
Arch Dermatol 1997;133:481-486.
ABSTRACT
Erythema Multiforme: Should Anyone Care About the Standards of Care?
Rasmussen
Arch Dermatol 1995;131:726-729.
ABSTRACT
Immune Mechanisms of TEN
Journal Watch Dermatology 1994;1994:10-10.
FULL TEXT
|